Emerald Clinical Trials Triumphs at 2026 Asia Pacific Biopharma Excellence Awards Emerald Clinical Trials has been awarded the prestigious 2026 Asia Pacific Biopharma Excellence Award for its extraordinary efforts in patient recruitment and engagement.

Emerald Clinical Trials Triumphs at 2026 Asia Pacific Biopharma Excellence Awards #Singapore #Patient_Engagement #Emerald_Clinical_Trials #Biopharma_Excellence

Emerald Clinical Trials Announces Leadership Change and Business Continuity Plans Emerald Clinical Trials has confirmed the appointment of Glenn Kerkhof as interim CEO following Mary Gunn's resignation, ensuring business continuity.

Emerald Clinical Trials Announces Leadership Change and Business Continuity Plans #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces CEO Transition and Succession Planning Strategy Emerald Clinical Trials has announced a significant leadership change, appointing Glenn Kerkhof as interim CEO following Mary Gunn's departure, ensuring operational stability.

Emerald Clinical Trials Announces CEO Transition and Succession Planning Strategy #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change and Continuity Plan Amid Transition Emerald Clinical Trials has confirmed a leadership change as Mary Gunn steps down. Glenn Kerkhof will serve as interim CEO while a permanent replacement is sought.

Emerald Clinical Trials Announces Leadership Change and Continuity Plan Amid Transition #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Transition and Continuity Plan Amidst Changes Emerald Clinical Trials has confirmed the transition of leadership with the appointment of Glenn Kerkhof as interim CEO following Mary Gunn's departure.

Emerald Clinical Trials Announces Leadership Transition and Continuity Plan Amidst Changes #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change with Glenn Kerkhof as Interim CEO Emerald Clinical Trials has announced a leadership transition with Glenn Kerkhof appointed as Interim CEO following Mary Gunn's departure.

Emerald Clinical Trials Announces Leadership Change with Glenn Kerkhof as Interim CEO #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change and Future Strategic Plans Emerald Clinical Trials, a top global provider in clinical research, confirms a leadership transition with Glenn Kerkhof stepping in as Interim CEO, ensuring continuity.

Emerald Clinical Trials Announces Leadership Change and Future Strategic Plans #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

George Clinical Rebrands to Emerald Clinical Trials: A New Era for Global Research Emerald Clinical Trials emerges as the new identity for George Clinical, highlighting the organization's commitment to reliable global clinical research.

George Clinical Rebrands to Emerald Clinical Trials: A New Era for Global Research #Singapore #Clinical_Research #Emerald_Clinical_Trials #Global_Trials

Emerald Clinical Trials: A New Era for Global Clinical Research Effectiveness Emerald Clinical Trials, formerly known as George Clinical, rebranded to reflect growth and commitment to reliable global clinical studies. Discover their innovative impact.

Emerald Clinical Trials: A New Era for Global Clinical Research Effectiveness #Singapore #George_Clinical #Clinical_Research #Emerald_Clinical_Trials

Emerald Clinical Trials: A New Chapter for George Clinical's Global Research Operations Emerald Clinical Trials, formerly George Clinical, has rebranded to enhance its commitment to innovation and transparency in global clinical research, ensuring reliable companion for pharma.

Emerald Clinical Trials: A New Chapter for George Clinical's Global Research Operations #Singapore #George_Clinical #Clinical_Research #Emerald_Clinical_Trials

George Clinical Transitions to Emerald Clinical Trials: A New Era in Clinical Research George Clinical announces its rebranding to Emerald Clinical Trials, reflecting its growth and commitment to transparency in global clinical studies.

George Clinical Transitions to Emerald Clinical Trials: A New Era in Clinical Research #Singapore #George_Clinical #Clinical_Research #Emerald_Clinical_Trials

Emerald Clinical Trials: New Name Reflects Commitment to Clinical Excellence and Innovation Emerald Clinical Trials, formerly George Clinical, announces a rebrand emphasizing its mission to enhance clinical research transparency and trust.

Emerald Clinical Trials: New Name Reflects Commitment to Clinical Excellence and Innovation #Singapore #George_Clinical #Emerald_Clinical_Trials #clinical_research_organization